• Human Actrapid® 10ml vial approved. 

• Approved formulations of Humulin® S include:
  
  • 10ml vials;
  • 5x3ml cartridges.
  
  

• Approved formulations for Fiasp® include:
  
  
  
  
  • 10ml vial;
  
  
  • 5x3ml cartridge;
  
  
  • 5x3ml FlexpTouch pen®.
  
  
  
  

• Approved formulations for Novorapid® include:
  
  • 10ml vial;
  • 5x3ml cartridge (for use with Novopen and Novopenmate devices);
  • 5x3ml Flexpen®.
• Approved formulations for Trurapi® include:
  • 100 units/ml 10ml vial
  • 100 units/ml cartridge
  • 100 units/ml pre-filled pen

Trurapi = BLACK TRIANGLE

• Approved formulations for Humalog 100 ® include:
  
  • 10ml vial;
  • 5x3ml cartridge;
  • 5x3ml Kwiikpen®.
• Prescriptions need to be written as Insulin Lispro Sanofi^® or Humalog^® to avoid prescribing/dispensing errors.
• Note that there are two strengths of Humalog® (insulin lispro). Caution should be exercised when prescribing and dispensing

• 200 units per ml
• Approved formulations for Humalog 200® include the 5x3ml Kwikpen^®.
• Note that there are two strengths of Humalog^® (insulin lispro). Caution should be exercised when prescribing and dispensing

• 100units /ml
• 10ml vial 3ml cartridges (for AllStar Pro and JuniorSTAR pen), 3ml SoloStar prefilled pen
• Prescriptions need to be written as Insulin Lispro Sanofi^® or Humalog^® to avoid prescribing/dispensing errors. Insulin lispro biosimilar

• Approved Apidra® formulations include:
  
  • 10ml vials;
  • 5x3ml cartridges
  • 5x3ml Solostar® pens.
  
  

• Humulin R 500units in 1ml (10ml vial) approved for a very small number of insulin resistant patients that require very high doses of insulin.